AI models predict when patients can safely stop long-term antidepressant use

An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›

At an explosive news conference on the causes of autism, President Donald Trump espoused decades-old, long-debunked theories linking autism to the childhood vaccine schedule.

California's far northern region is a collection of sparsely populated counties stretching from just north of Sacramento all the way up to Oregon and from the Pacific coast to the Nevada border. The shortage of doctors is so pervasive that support for one of the costliest solutions—a proposed $200 million health care training campus—transcends partisanship.

President Donald Trump's announcement advising Americans against taking acetaminophen during pregnancy to avoid the chance of autism was met with pushback from some lawmakers, including a key GOP health figure.

Biologist Grant Hokit went to a small meadow in the mountains outside Condon, Montana, to look for ticks. A hiking path crossed the expanse of long grasses and berry bushes.

Cardiovascular diseases (CVD) remain the leading cause of disease burden, causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of risks, including increasing rates of obesity and diabetes, according to the latest Global Burden of Disease (GBD) Study special report published in the Journal of the American College of Cardiology (JACC).

It may not be age that is making your hair thin or fall out, but rather what you are eating and drinking.

Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study and alter neurophysiological processes. These include CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a sophisticated tool to edit specific genes in some animals, including mice, rats, zebrafish and fruit flies.

New machine learning models developed by University of South Australia (UniSA) researchers could help clinicians identify when patients can successfully stop long-term antidepressant use.

Frequent exercise doesn't just strengthen the heart—it also changes the nerves that control it, according to new research which could guide more targeted and effective care for common heart problems.

A major UK study has revealed that the early warning signs of multiple sclerosis (MS)—including pain, mood changes, and neurological symptoms such as numbness and tingling—may appear years before diagnosis and affect all communities in similar ways.

Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go 'rogue' in many different diseases affecting multiple organs—from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease.

Consuming some types of fruits and vegetables can increase the levels of harmful pesticides detected in people's bodies, according to a new study by Environmental Working Group scientists.

How fat is distributed in people's bodies could make a difference to their risk of certain cancers, according to new research led by the University of Bristol. The study is published in JNCI: Journal of the National Cancer Institute.

There's been a significant rise in the use of low- and alcohol-free drinks to curb alcohol intake among "risky drinkers" over the past five years in England, Wales, and Scotland, finds research published in BMJ Public Health.

BMJ Group has retracted research suggesting that small daily quantities of apple cider vinegar might help people who are overweight or obese to lose weight.

Drinking any amount of alcohol likely increases the risk of dementia, suggests the largest combined observational and genetic study to date, published in BMJ Evidence-Based Medicine.

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.